ZYNERBA PHARMACEUTICALS, INC. Financing Cash Flow
ZYNERBA PHARMACEUTICALS, INC. reported Financing Cash Flow of $1.72 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2023-08-14
- ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2023-06-30 was -$6.71K, a 100.99% decline year-over-year.
- ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2023-03-31 was $1.73M, a 0.67% decline year-over-year.
- ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2022-12-31 was $399.35K.
- ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2022-09-30 was $3.20M.
- ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2022 was $6.01M, a 85.73% decline from fiscal 2021.
- ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2021 was $42.16M, a 36.63% increase from fiscal 2020.
- ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2020 was $30.85M, a 31.81% decline from fiscal 2019.
- ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2019 was $45.25M, a 51.14% increase from fiscal 2018.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$6.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.72M 10-Q · filed 2023-08-14 | $2.12M derived: sum of 3 quarters · filed 2023-08-14 | $5.32M derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | $1.73M 10-Q · filed 2023-05-15 | $2.13M derived: sum of 2 quarters · filed 2023-05-15 | $5.33M derived: sum of 3 quarters · filed 2023-05-15 | $6.00M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | $399.35K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $3.60M derived: sum of 2 quarters · filed 2023-03-28 | $4.27M derived: sum of 3 quarters · filed 2023-08-14 | $6.01M 10-K · filed 2023-03-28 |
| 2022-09-30 | $3.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $3.87M derived: sum of 2 quarters · filed 2023-08-14 | $5.61M 10-Q · filed 2022-11-14 | $5.61M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | $675.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.42M 10-Q · filed 2023-08-14 | $2.42M derived: sum of 3 quarters · filed 2023-08-14 | $2.32M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $1.74M 10-Q · filed 2023-05-15 | $1.74M derived: sum of 2 quarters · filed 2023-05-15 | $1.65M derived: sum of 3 quarters · filed 2023-05-15 | $1.63M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$92.03K derived: sum of 2 quarters · filed 2023-03-28 | -$110.11K derived: sum of 3 quarters · filed 2023-03-28 | $42.16M 10-K · filed 2023-03-28 |
| 2021-09-30 | -$92.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$110.11K derived: sum of 2 quarters · filed 2022-11-14 | $42.16M 10-Q · filed 2022-11-14 | $44.05M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-06-30 | -$18.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $42.25M 10-Q · filed 2022-08-10 | $44.14M derived: sum of 3 quarters · filed 2023-03-28 | $44.14M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-03-31 | $42.27M 10-Q · filed 2022-05-16 | $44.16M derived: sum of 2 quarters · filed 2023-03-28 | $44.16M derived: sum of 3 quarters · filed 2023-03-28 | $71.41M derived: sum of 4 quarters · filed 2023-03-28 |
| 2020-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $1.89M derived: sum of 2 quarters · filed 2023-03-28 | $29.14M derived: sum of 3 quarters · filed 2023-03-28 | $30.85M 10-K · filed 2023-03-28 |
| 2020-09-30 | -$4.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $27.25M derived: sum of 2 quarters · filed 2021-11-15 | $28.96M 10-Q · filed 2021-11-15 | $28.99M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $27.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $28.96M 10-Q · filed 2021-08-09 | $28.99M derived: sum of 3 quarters · filed 2022-03-01 | $28.92M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $1.71M 10-Q · filed 2021-05-12 | $1.74M derived: sum of 2 quarters · filed 2022-03-01 | $1.67M derived: sum of 3 quarters · filed 2022-03-01 | $28.88M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $28.91K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$43.96K derived: sum of 2 quarters · filed 2022-03-01 | $27.17M derived: sum of 3 quarters · filed 2022-03-01 | $45.25M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$72.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $27.14M derived: sum of 2 quarters · filed 2020-11-09 | $45.22M 10-Q · filed 2020-11-09 | $45.14M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | $27.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $45.29M 10-Q · filed 2020-08-10 | $45.21M derived: sum of 3 quarters · filed 2021-03-10 | |
| 2019-03-31 | $18.08M 10-Q · filed 2020-05-11 | $18.00M derived: sum of 2 quarters · filed 2021-03-10 | ||
| 2018-12-31 | -$76.51K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $29.94M 10-K · filed 2021-03-10 | ||
| 2018-09-30 | $30.01M 10-Q · filed 2019-11-06 | |||
| 2017-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $2.89M derived: sum of 2 quarters · filed 2020-03-10 | $3.26M derived: sum of 3 quarters · filed 2020-03-10 | $57.50M 10-K · filed 2020-03-10 |
| 2017-09-30 | -$107.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $259.68K derived: sum of 2 quarters · filed 2018-11-08 | $54.51M 10-Q · filed 2018-11-08 | $59.22M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-06-30 | $367.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $54.61M 10-Q · filed 2018-08-02 | $59.33M derived: sum of 3 quarters · filed 2019-03-11 | |
| 2017-03-31 | $54.25M 10-Q · filed 2018-05-08 | $58.96M derived: sum of 2 quarters · filed 2019-03-11 | ||
| 2016-12-31 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | $10.00M 10-K · filed 2019-03-11 | ||
| 2016-09-30 | $5.29M 10-Q · filed 2017-11-14 | |||
| 2015-12-31 | -$59.30K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $42.24M derived: sum of 2 quarters · filed 2018-03-12 | $42.22M derived: sum of 3 quarters · filed 2018-03-12 | $42.19M 10-K · filed 2018-03-12 |
| 2015-09-30 | $42.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $42.28M derived: sum of 2 quarters · filed 2016-11-14 | $42.24M 10-Q · filed 2016-11-14 | $48.68M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | -$20.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$53.63K 10-Q · filed 2016-08-11 | $6.38M derived: sum of 3 quarters · filed 2016-08-11 | $11.97M derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | -$33.00K 10-Q · filed 2016-05-12 | $6.40M derived: sum of 2 quarters · filed 2016-05-12 | $11.99M derived: sum of 3 quarters · filed 2016-05-12 | |
| 2014-12-31 | $6.44M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $12.03M derived: sum of 2 quarters · filed 2016-03-14 | $12.74M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $5.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $6.30M 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $711.32K 10-Q · filed 2015-08-27 | |||
| 2013-12-31 | $109.46K 10-K · filed 2016-03-14 |